| answer text |
<p>The Joint Committee on Vaccination and Immunisation, having looked at a wide range
of evidence, concluded that only a subset of those with asthma are at clinically higher
risk from COVID-19. This group is defined as adults with asthma who require continuous
or repeated use of systemic steroids or with previous exacerbations requiring hospital
admission. They will be vaccinated in priority group six. Some individuals with more
severe asthma may also be included in the clinically extremely vulnerable group, in
which case they will be vaccinated in priority group four.</p>
|
 |
